Mid-Childhood Outcomes of Repeat Antenatal Corticosteroids: A Randomized Controlled Trial
Authors:
- Caroline A. CrowtherCCCaroline A. Crowther
- Peter J. AndersonPAPeter J. Anderson
- Christopher J.D. McKinlayCMChristopher J.D. McKinlay
- Lex W. DoyleLDLex W. Doyle
- for the ACTORDS Follow-up GroupFGfor the ACTORDS Follow-up Group
- 1 October 2016
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 138 (4)
Abstract
OBJECTIVE: To assess if exposure to repeat dose(s) of antenatal corticosteroids has beneficial effects on neurodevelopment and general health in mid-childhood, at 6 to 8 years’ corrected age. METHODS: Women at risk for very preterm birth, who had received a course of corticosteroids ≥7 days previously, were randomized to intramuscular betamethasone (11.4 mg Celestone Chronodose) or saline placebo, repeated weekly if risk of very preterm birth remained. Mid-childhood assessments included neurocognitive function, behavior, growth, lung function, blood pressure, health-related quality of life, and health service utilization. The primary outcome was survival free of neurosensory disability. RESULTS: Of the 1059 eligible long-term survivors, 963 (91%) were included in the primary outcome; 479 (91%) in the repeat corticosteroid group and 484 (91%) in the placebo group. The rate of survival free of neurosensory disability was similar in both groups (78.3% repeat versus 77.3% placebo; risk ratio 1.00, 95% confidence interval, 0.94–1.08). Neurodevelopment, including cognitive function, and behavior, body size, blood pressure, spirometry, and health-related quality of life were similar in both groups, as was the use of health services. CONCLUSIONS: Treatment with repeat dose(s) of antenatal corticosteroids was associated with neither benefit nor harm in mid-childhood. Our finding of long-term safety supports the use of repeat dose(s) of antenatal corticosteroids, in view of the related neonatal benefits. For women at risk for preterm birth before 32 weeks’ gestation, ≥7 days after an initial course of antenatal corticosteroids, clinicians could consider using a single injection of betamethasone, repeated weekly if risk remains.Keywords
This publication has 28 references indexed in Scilit:
- Attention Problems in a Representative Sample of Extremely Preterm/Extremely Low Birth Weight ChildrenDevelopmental Neuropsychology, 2011
- Revised birth centiles for weight, length and head circumference in the UK-WHO growth chartsAnnals of Human Biology, 2010
- The stability of the diagnosis of developmental disability between ages 2 and 8 in a geographic cohort of very preterm children born in 1997Archives of Disease in Childhood, 2009
- Reference Ranges for Spirometry Across All AgesAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Outcomes at 2 Years of Age after Repeat Doses of Antenatal CorticosteroidsNew England Journal of Medicine, 2007
- Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis functionJournal of Clinical Investigation, 2007
- Blood pressure centiles for Great BritainArchives of Disease in Childhood, 2006
- Assessment and Development of Organizational Ability: The Rey Complex Figure Organizational Strategy Score (RCF-OSS)*The Clinical Neuropsychologist, 2001
- Identification and Description of New Tests of Executive Functioning in ChildrenChild Neuropsychology, 1999
- Comprehensive assessment of the health status of extremely low birth weight children at eight years of age: Comparison with a reference groupThe Journal of Pediatrics, 1994